CRISPR Market
According to Intent Market Research, the CRISPR Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 15.0% to touch USD 8.7 billion by 2030. The CRISPR market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Agilent Technologies, Lonza, PerkinElmer, CRISPR Therapeutics, Intellia Therapeutics, Beam Therapeutics, and Danaher.